Literature DB >> 12436238

First year experience of patients undergoing the Stretta procedure.

H Houston1, L Khaitan, M Holzman, W O Richards.   

Abstract

BACKGROUND: The Stretta procedure is a new, totally endoscopic treatment for GERD, where radiofrequency energy is delivered to the smooth muscle of the gastroesophageal junction.
METHODS: Forty-one patients undergoing the Stretta procedure between August 2000 and August 2001 were prospectively evaluated. Under an IRB-approved protocol, patients were studied preoperatively and postoperatively with esophageal manometry, 24-h pH testing, SF12 surveys, and GERD-specific questionnaires (QOLRAD).
RESULTS: Results are reported as mean +/- SEM. All procedures were performed on an outpatient basis; 33 were under conscious sedation and 8 were under general anesthesia. Prior to treatment, patients had a mean LES pressure of 25 +/- 2.4 mmHg, Johnson-Demeester score of 32.8 +/- 4.6 mmHg, and % time reflux 8.4 +/- 0.9%. The quality-of-life scores were significantly improved at 6 months: QOLRAD score increased from 3.7 +/- 0.2 to 5.1 +/- 0.2 (p = 0.002), SF12 mental score increased from 44.3 +/- 2.0 to 51.8 +/- 1.7 (p = 0.001), and SF12 physical score increased from 26.2 +/- 2.4 to 33.1 +/- 3.8 (p = 0.001). Eighteen patients returned for esophageal manometry and 24-h pH testing at a mean of 6.8 +/- 0.5 months. There was a significant decrease in esophageal acid exposure time (8.4 +/- 0.9% to 4.4 +/- 1.3%, p = 0.03) and Johnson-Demeester score (32.8 +/- 4.6 to 22.9 +/- 5.3, p = 0.04). There was no significant change in mean LES pressure (25.3 +/- 2.4 mmHg to 26.8 +/- 2.6 mmHg, p = 0.63). Twenty of 31 patients (65%) available for 6 months follow-up were completely off proton pump inhibitors. The only complication related to Stretta was a case of gastroparesis 10 days post-operatively that resolved completely.
CONCLUSIONS: The Stretta procedure is a promising new endoscopic treatment for GERD. It significantly improves GERD symptoms and quality of life while eliminating the need for proton pump inhibitors in the majority of patients.

Entities:  

Mesh:

Year:  2002        PMID: 12436238     DOI: 10.1007/s00464-002-8923-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

Review 1.  Endoscopic antireflux procedures.

Authors:  J Arts; J Tack; J P Galmiche
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

2.  Minimally invasive surgical approach for the treatment of gastroparesis.

Authors:  Joerg Zehetner; Farrokh Ravari; Shahin Ayazi; Afshin Skibba; Ali Darehzereshki; Diana Pelipad; Rodney J Mason; Namir Katkhouda; John C Lipham
Journal:  Surg Endosc       Date:  2012-06-30       Impact factor: 4.584

Review 3.  Endoluminal and transluminal surgery: current status and future possibilities.

Authors:  A Malik; J D Mellinger; J W Hazey; B J Dunkin; B V MacFadyen
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

4.  The Secca procedure for the treatment of fecal incontinence: definitive therapy or short-term solution.

Authors:  Christine J Parisien; Marvin L Corman
Journal:  Clin Colon Rectal Surg       Date:  2005-02

5.  Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease.

Authors:  A Torquati; H L Houston; J Kaiser; M D Holzman; W O Richards
Journal:  Surg Endosc       Date:  2004-07-22       Impact factor: 4.584

6.  Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication.

Authors:  Phuong Huynh; Vani Konda; Suchakree Sanguansataya; Marc A Ward; Steven G Leeds
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2020-12-16       Impact factor: 1.719

7.  Delivery of radiofrequency energy to the gastroesophageal junction (Stretta procedure) for the treatment of gastroesophageal reflux disease.

Authors:  L Cipolletta; G Rotondano; L Dughera; A Repici; M A Bianco; C De Angelis; A M Vingiani; E Battaglia
Journal:  Surg Endosc       Date:  2005-05-03       Impact factor: 4.584

Review 8.  Endoscopic treatment modalities for gastroesophageal reflux disease.

Authors:  R E Lutfi; A Torquati; W O Richards
Journal:  Surg Endosc       Date:  2004-07-15       Impact factor: 4.584

9.  Paradigm shift in the management of gastroesophageal reflux disease.

Authors:  William O Richards; Hugh L Houston; Alfonso Torquati; Leena Khaitan; Michael D Holzman; Kenneth W Sharp
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

10.  Endoluminal fundoplication by a transoral device for the treatment of GERD: A feasibility study.

Authors:  G B Cadière; A Rajan; O Germay; J Himpens
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.